RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) announces today that Bayer Corporation (“Bayer”) has agreed to pay $40 million to resolve claims in two longstanding, whistleblower lawsuits alleging that Bayer violated anti-fraud laws in selling and promoting three drugs, Trasylol, Avelox and Baycol. In addition, Bayer agreed to pay a separate amount to resolve claims that it unlawfully retaliated against the whistleblower who raised her concerns to superiors.
“This case again reaffirms the critical role that whistleblowers can play. Our client courageously stepped forward to challenge Bayer’s conduct and demonstrated incredible dedication and sacrifice in pursuing these matters for so long”
Tweet this
The cases were brought under the False Claims Act by a former Bayer employee, on behalf of the United States and numerous states. The settlement covers two whistleblower lawsuits. The first, U.S. ex rel. Simpson v. Bayer Corp., et al. (D.N.J.) filed in 2005, alleged that Bayer paid illegal kickbacks in connection with two drugs, Trasylol and Avelox; promoted Trasylol for uses that were not reasonable and necessary under Medicare’s payment rules; and terminated the whistleblower for raising concerns internally. In the Complaint, Bayer was alleged to have paid illegal kickbacks to healthcare providers in the form of honoraria, grants, speaker program fees, entertainment, travel and other benefits, including to attend medical...
US President made 7 claims, all false: Iran warns of closing Hormuz amid naval blockade: File photo (Source: Xinhua/IANS) Tehran, April 18 (IANS) Iran’s Parliament Speaker Mohammed Bagher Ghalibaf...